For millions of households across the United States, the gas stove has long been a staple of the kitchen, valued…
Read More
Evaluating ERS 2026 Insights on Biologic Therapies for Obesity-Driven Asthma Phenotypes
The intersection of metabolic disease and respiratory medicine has emerged as one of the most critical frontiers in modern clinical…
Read More
ERS 2026 Insights: Body Mass Index and Type 2 Inflammation as Major Predictors of Asthma Attack Risk
Respiratory medicine continues to evolve as researchers uncover complex interactions between metabolic health, systemic inflammation, and chronic airway diseases. Among…
Read More
A novel ‘asthma-on-a-chip’ platform breathes new life into study of the condition, offering hope for future treatments.
Engineers at the University of Pennsylvania (PA, USA) have engineered a groundbreaking human lung-on-a-chip technology, capable of replicating the intricate…
Read More
NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK
In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
